Health Condition 1: R112- Nausea with vomiting, unspecified
Conditions
Interventions
Intervention1: palonosetron: 5HT3 receptor antagonist,given by intravenous injection,OD,dose-0.075mg
Control Intervention1: Aprepitant: NK1 receptor antagonist,oral route,dose 40mg,OD
Sponsors
VIMSAR
Eligibility
Inclusion criteria
Inclusion criteria: Females aged 20 to 65 yrs of ASA Class1 and 2 scheduled to undergo laparascopic surgery
Exclusion criteria
Exclusion criteria: 1.pregnancy 2.weight 100 3.smokers 4.history of PONV 5.steroid use 6.abnormal liver function test 7.abnormal renal function test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparative incidence of postoperative nausea and vomiting in patients undergoing laparoscopic procedures who have been administered palonosetron or aprepitantTimepoint: Comparative incidence of postoperative nausea and vomiting in patients undergoing laparoscopic procedures who have been administered palonosetron or aprepitant at 2hr,6hr,12hr,24hr,48hr after extubation | — |
Secondary
| Measure | Time frame |
|---|---|
| need for use of an additional anti emetic in post operative periodTimepoint: immediately after extubation 2 hr after extubation 6 hr after extubation 12 hr after extubation 24 hr after extubation 48 hr after extubation;need for use of an analgesic in post operative periodTimepoint: immediately after extubation 2 hr after extubation 6 hr after extubation 12 hr after extubation 24 hr after extubation 48 hr after extubation | — |
Countries
India
Contacts
Public ContactDr Subhashree Mishra
VIMSAR
Outcome results
None listed